FarmaMondo SA, the world’s leader in managing paid-access to unlicensed medicines, has been appointed by Amomed Pharma to exclusively distribute Empressin® via a Managed Access Program for targeted Healthcare Providers in Russia and CIS region. FarmaMondo to manage access to Empressin for patients with septic shock in Russia, Belarus, Kazakhstan,...

FarmaMondo celebrates the recent successful establishment of its subsidiary in Copenhagen covering all 5 Nordic countries representing more than 27 million people. The Nordic expansion comes as a follow up to previous successful expansion to LATAM, Asia and CIS regions. FarmaMondo continues to invest...

Read the full interview, appeared on the magazine Healthcare and Life Sciences Review with our CEO, Mr. Jaron Spigel, regarding the uniqueness of FarmaMondo business model. With two billion people globally – predominantly in low and middle-income countries – having little or no access to medicine, a select group...

FarmaMondo SA announces it has established operations through its Global Access business unit into several south EU markets to allow direct to hospital supply of unlicensed medicines. The South European markets (Portugal, Spain, Italy and Greece) present a unique business and regulatory environment in the context of unlicensed medicines...

FarmaMondo Team is pleased to inform you that also for 2018 is attending Arab Health in Dubai. Arab Health is the largest gathering of healthcare and trade professionals in the MENA region. The 2018 edition of the event is expected to welcome more than 4,200 exhibiting companies and 103,000...

FarmaMondo has recently hosted two days of medical workshops in Saint Petersburg and Moscow on November 9th and 10th 2017, as part of its support for the exclusive managed access program of Dinutuximab beta EUSA to fulfill the unmet medical needs of patients with high-risk neuroblastoma, in all the CIS...

FarmaMondo SA, the world’s leader in managing paid-access to unlicensed medicines, has been appointed by EUSA Pharma to exclusively distribute Qarziba® via a Managed Access Program for targeted Healthcare Providers in Russia and CIS region. FarmaMondo to manage access to Qarziba® for patients with high risk neuroblastoma in Russia, Belarus,...

Following the successful and great experience of last 2 years’ participation FarmaMondo will return again to exhibit at EXPOPHARM 2017which will be held in Düsseldorf, Germany from September 13 to September 15, 2017 FarmaMondo Team will be pleased to host you in our stand at Hall 5 booth A-21 to...

FarmaMondo is delighted to announce further expansion of its Russian operations. As of July 1st 2017 FarmaMondo Representative Office (Moscow, Russia) provides full service coverage to all Commonwealth Independent States (CIS) region. The enlarged Representative Office is a part of FarmaMondo’s global strategy of putting in place localized solutions...